Staphylococcus aureus tetrapeptide with high chemotactic potency and efficacy for human leukocytes

Area of Science:

• Microbiology
• Immunology
• Biochemistry

Background:

• Staphylococcus aureus produces chemotactic factors that influence host immune responses.
• Formyl-methionyl peptides are known chemoattractants for human monocytes.
• The formyl-methionyl peptide receptor (FPR) plays a crucial role in monocyte recruitment.

Purpose of the Study:

• To purify and characterize a novel chemotactic tetrapeptide from Staphylococcus aureus.
• To investigate the interaction of this peptide with the formyl-methionyl peptide receptor on human monocytes.
• To assess the chemotactic efficacy of the purified peptide.

Main Methods:

• Purification of the peptide using reverse-phase high-pressure liquid chromatography.
• Inhibition assays to study the binding of the peptide to human monocyte formyl-methionyl peptide receptors.
• Dose-response curve analysis to compare receptor affinity.
• Chemotaxis assays to measure monocyte migration.

Main Results:

• A homogeneous chemotactic tetrapeptide composed of methionine, leucine, isoleucine, and phenylalanine was isolated.
• The bacterial peptide inhibited the binding of a known formyl-methionyl peptide to human monocytes, indicating interaction with the FPR.
• The peptide's receptor affinity was comparable to that of fMet-Leu-Phe-Lys.
• The peptide demonstrated a higher chemotactic efficacy (53%) compared to the reference attractant fMet-Leu-Phe (36%).

Conclusions:

• Staphylococcus aureus produces a potent chemoattractant peptide that targets the human monocyte formyl-methionyl peptide receptor.
• This bacterial peptide is capable of attracting all receptor-bearing human monocytes.
• The findings highlight a potential mechanism for bacterial manipulation of host immune cell migration.